Your search returned 1978 results.

Results
	41.	Questions to the article by Boyer et al. [electronic resource] by Xu, Danyan Chen, Jingyuan Wu, Chenlu Guo, Yuan Gui, Yajun Producer: 20190103 In: Journal of clinical lipidology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	PCSK9 Inhibitors Prior Authorization. [electronic resource] by Nasir, Khurram Angraal, Suveen Virani, Salim S Producer: 20200417 In: Circulation. Cardiovascular quality and outcomes vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	Screening for High Lipoprotein(a). [electronic resource] by Thanassoulis, George Producer: 20191219 In: Circulation vol. 139 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	44.	Tracing new atherogenic properties of PCSK9: Another insight into the pathogenesis of atherosclerosis 'the Minotaur's labyrinth'. [electronic resource] by Rallidis, Lοukianos S Producer: 20200518 In: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	Interindividual and Intraindividual Responses to PCSK9 Inhibition. [electronic resource] by Thompson, Paul D Producer: 20200603 In: JAMA cardiology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	46.	PCSK9 Function and Cardiovascular Death: The Knot Tightens. [electronic resource] by Schwartz, Gregory G Taylor, Matthew R G Producer: 20200402 In: Journal of the American College of Cardiology vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	47.	FOURIER to ODYSSEY: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodies. [electronic resource] by Sabouret, Pierre Angoulvant, Denis Pathak, Atul Producer: 20190723 In: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	48.	Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. [electronic resource] by Schmidt, Amand F Pearce, Lucy S Wilkins, John T Casas, Juan P Hingorani, Aroon D Producer: 20190115 In: Heart (British Cardiac Society) vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	49.	EGF-A peptides: A promising strategy for PCSK9 inhibition. [electronic resource] by Cariou, Bertrand Dijk, Wieneke Producer: 20200219 In: Atherosclerosis vol. 292 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	50.	The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients. [electronic resource] by Rallidis, Loukianos S Producer: 20200219 In: Atherosclerosis vol. 292 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	51.	Non-HDL cholesterol series: PCSK9 inhibitor new season! [electronic resource] by Gaita, Dan Gaita, Laura Mihaescu, Adelina Producer: 20210308 In: European journal of preventive cardiology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	52.	Are anti-inflammatory agents and nutraceuticals - novel inhibitors of PCSK9? [electronic resource] by Shafabakhsh, Rana Reiner, Željko Hallajzadeh, Jamal Mirsafaei, Liaosadat Asemi, Zatollah Producer: 20201215 In: Critical reviews in food science and nutrition vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	53.	PCSK9 inhibitors in the current management of atherosclerosis. [electronic resource] by Whayne, Thomas F Producer: 20170418 In: Archivos de cardiologia de Mexico vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	54.	PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Status and Protection Against Ischemic Stroke: PheWAS, TreWAS, and More. [electronic resource] by Sullivan, David Bonnitcha, Paul Spinks, Catherine Keech, Tony Producer: 20190613 In: Circulation. Genomic and precision medicine vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	55.	Reply to "PCSK9: Entering a new era of cardiovascular risk prediction". [electronic resource] by Liberale, Luca Bonaventura, Aldo Carbone, Federico Montecucco, Fabrizio Producer: 20190327 In: International journal of cardiology vol. 274 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	56.	PCSK9 inhibition and diabetes: turning to Mendel for clues. [electronic resource] by Lee, Jooho Hegele, Robert A Producer: 20190812 In: The lancet. Diabetes & endocrinology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	57.	Diabetes: PCSK9 inhibition is not associated with new-onset diabetes. [electronic resource] by Fernández-Ruiz, Irene Producer: 20180830 In: Nature reviews. Cardiology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	58.	PCSK9: A link between air pollution and cardiovascular disease? [electronic resource] by Prochaska, Jürgen H Tröbs, Sven-Oliver Wild, Philipp S Producer: 20200820 In: European journal of preventive cardiology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	59.	PCSK9 inhibition and type 2 diabetes. [electronic resource] by Lotta, Luca A Griffin, Simon J Producer: 20180423 In: The lancet. Diabetes & endocrinology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	60.	Interindividual and Intraindividual Responses to PCSK9 Inhibition-Reply. [electronic resource] by Qamar, Arman Giugliano, Robert P Sabatine, Marc S Producer: 20200603 In: JAMA cardiology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.